• Investigational Antibody IgG1-iS18 Reduces Amyloid Load, Improves Memory in Mice
  • Efforts to Mark World Alzheimer’s Day, Sept. 21, and Month Are Well Underway
  • Nuplazid More Effective in Reducing Severe Psychosis in Alzheimer’s, Trial Shows
  • Age, Gender, and APOE4 Variant May Help Identify Those at High Risk for Dementia, Study Suggests
  • Phase 3 Trial Results Suggest Flortaucipir Tracer Agent Can Help Predict Alzheimer’s Diagnosis
  • Excessive Daytime Sleepiness Associated With Alzheimer’s Risk, Long-term Study Reports
  • Peptide Found in Sea Anemones Might Give Rise to Alzheimer’s Treatment, Study Says
  • Aducanumab Continues to Show Potential as Treatment for Mild Alzheimer’s in Long-term Extension of PRIME Trial
  • Non-Invasive Eye Exam Might Help Predict Risk for Alzheimer’s, Study Suggests
  • Synaptic Protein Makeup May Explain Why Not All People with Alzheimer’s Brain Markers Develop Dementia
  • ProMIS’ PMN310 Shows Improved Safety Profile, Specificity Compared to Similar Alzheimer’s Candidates
  • New Gene Variants Identified as Potential Risk Factors for Alzheimer’s